Those Who Invested in Bruker (NASDAQ:BRKR) Five Years Ago Are up 32%
Express News | Bruker Posted Bond In Order To Suspend Injunction That Had Been Impacting Sales Of CosMx Spatial Molecular Imager Products By Its NanoString Business In Germany
Bruker: Suspension Due to Ongoing Patent Litigation With 10x Genomics, During an Appeal Process in Germany >BRKR
Express News | Bruker: Effective Immediately, All Cosmx Products Available to German Scientific Instrument Customers
Express News | Bruker Announces That Injunction Impacting Nanostring’s Cosmx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
Zhonglun New Material (301565.SZ): will continue to introduce advanced production lines from Bruker Corp in Germany in the future.
On July 17th, Gelunhui reported that Zhonglun New Material (301565.SZ) recently stated during a reception with institutional investors that with the continuous development of production technology, the global BOPA film production equipment has been continuously improved in width from 4.2 meters to 7.4 meters in recent years, and the production scale of a single production line has been continuously improved. At present, as a leading enterprise in the BOPA film industry, the company owns a Germany Bruker corp magnetic suspension production line and a 7.4-meter production line (with a single-line design capacity of about 0.02 million tons per year) that represents international leading level. Through years of operation, the company continuously optimizes and improves production technology and equipment on a unit basis.
Express News | Bruker Corp : TD Cowen Cuts Target Price to $74 From $80
Trending Industry Today: American Superconductor Leads Gains In Room-Temperature Superconductor Stocks
Bruker Price Target Cut to $80.00/Share From $95.00 by Citigroup
Bruker Is Maintained at Buy by Citigroup
Express News | Citigroup Maintains Buy on Bruker, Lowers Price Target to $80
Express News | Bruker Corp : Citigroup Cuts Target Price to $80 From $95
Citi Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $80
Bruker Is Maintained at Sell by Goldman Sachs
Bruker Price Target Cut to $60.00/Share From $72.00 by Goldman Sachs
Express News | Goldman Sachs Maintains Sell on Bruker, Lowers Price Target to $60
Bruker Analyst Ratings
Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds
Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie (FMP) in Berlin
Bruker Corp: Strong Buy Recommendation on Market Leadership and Strategic Acquisitions